News Release

<< Back

Sunesis Pharmaceuticals to Present at Needham Biotechnology & Medical Technology Conference


SOUTH SAN FRANCISCO, Calif., June 8, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) today announced that Daniel N. Swisher, Sunesis' Chief Executive Officer and President, will present a company update at the 6th Annual Needham Biotechnology & Medical Technology Conference on Thursday, June 14, 2007 at 9:30 a.m. Eastern Time at the New York Palace Hotel in New York City.

Interested parties may access the webcast of the presentation by visiting the Sunesis website at A replay of the webcast will be archived on the "Calendar of Events" page in the Investors and Media section of the Sunesis website for two weeks until June 28, 2007.

About Sunesis Pharmaceuticals

Sunesis is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel small molecule therapeutics for oncology and other serious diseases. Sunesis has built a broad product candidate portfolio through internal discovery and in-licensing of novel cancer therapeutics. Sunesis is advancing its product candidates through in-house research and development efforts and strategic collaborations with leading pharmaceutical and biopharmaceutical companies. For additional information on Sunesis Pharmaceuticals, please visit

Forward-Looking Statements

This press release may contain forward-looking statements that involve substantial risks and uncertainties. Sunesis may not actually achieve the plans, intentions or expectations contained in such forward-looking statements. Actual results or events could differ materially from the plans, intentions and expectations contained in such forward-looking statements. Sunesis does not assume any obligation to update any such forward-looking statements.

SOURCE Sunesis Pharmaceuticals, Inc.

Investors, Eric Bjerkholt, SVP, Corp. Development & Finance of Sunesis
Pharmaceuticals, Inc., +1-650-266-3717; or media, Karen L. Bergman, +1-650-575-1509,
or Michelle Corral, +1-415-794-8662, both of BCC Partners, for Sunesis
Pharmaceuticals, Inc.

Copyright (C) 2007 PR Newswire. All rights reserved

News Provided by COMTEX